Cited by 279Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Open access

Langbaum, Jessica B.S., Chen, Kewei, Lee, Wendy, Reschke, Cole, Bandy, Dan, Fleisher, Adam S., Alexander, Gene E., Foster, Norman L., Weiner, Michael W., Koeppe, Robert A., Jagust, William J., Reiman, Eric M.·2009·NeuroImage

DOI 10.1016/j.neuroimage.2008.12.072PMC PMC2886795

Open this paper in CoChat — free account

Abstract

In mostly small single-center studies, Alzheimer's disease (AD) is associated with characteristic and progressive reductions in fluorodeoxyglucose positron emission tomography (PET) measurements of the regional cerebral metabolic rate for glucose (CMRgl). The AD Neuroimaging Initiative (ADNI) is acquiring FDG PET, volumetric magnetic resonance imaging, and other biomarker measurements in a large longitudinal multi-center study of initially mildly affected probable AD (pAD) patients, amnestic mild cognitive impairment (aMCI) patients, who are at increased AD risk, and cognitively normal controls (NC), and we are responsible for analyzing the PET images using statistical parametric mapping (SPM). Here we compare baseline CMRgl measurements from 74 pAD patients and 142 aMCI patients to those from 82 NC, we correlate CMRgl with categorical and continuous measures of clinical disease severity, and we compare apolipoprotein E (APOE) varepsilon4 carriers to non-carriers in each of these subject groups. In comparison with NC, the pAD and aMCI groups each had significantly lower CMRgl bilaterally in posterior cingulate, precuneus, parietotemporal and frontal cortex. Similar reductions were observed when categories of disease severity or lower Mini-Mental State Exam (MMSE) scores were correlated with lower CMRgl. However, when analyses were restricted to the pAD patients, lower MMSE scores were significantly correlated with lower left frontal and temporal CMRgl. These findings from a large, multi-site study support previous single-site findings, supports the characteristic pattern of baseline CMRgl reductions in AD and aMCI patients, as well as preferential anterior CMRgl reductions after the onset of AD dementia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2008.12.072

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citation
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Self-citation
Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Self-citation
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Self-citation
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Self-citation

Show all 59 references

Research works printed but not linked: 1

De, 2001, Hippocampal formation glucose metabolism and volume losses in MCI and AD, Neurobiol. Aging, 22, 529, 10.1016/S0197-4580(01)00230-5 · DOI · Paper page

Sorted by citations

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,271
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,033
Self-citation
Brain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875
Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
Baker, L. D., Cross, D. J., Minoshima, S., Belongia, D., Watson, G. S., & Craft, S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.225 · Cited by 639
Functional connectivity density mapping
Tomasi, D. G., & Volkow, N. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001414107 · Cited by 645
A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages
Rathore, S., Habes, M., Iftikhar, M. A., Shacklett, A., & Davatzikos, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.03.057 · Cited by 622
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S. C., Nugent, S., Roy, M., Courchesne‐Loyer, A., Croteau, É., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 633
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603
The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L. M. J., Saykin, A. J., Morris, J. C., Cairns, N. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 613
Self-citation
Energetic cost of brain functional connectivity
Tomasi, D. G., Wang, G., & Volkow, N. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303346110 · Cited by 581
Aging and functional brain networks
Tomasi, D., & Volkow, N. D. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.81 · Cited by 578
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
Jagust, W. J., Bandy, D., Chen, K., Foster, N. L., Landau, S. M., Mathis, C. A., Price, J. C., Reiman, E. M., Skovronsky, D., Koeppe, R. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.003 · Cited by 542
Self-citation
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.172 · Cited by 497
Self-citation
Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 501
Self-citation
Random forest-based similarity measures for multi-modal classification of Alzheimer's disease
Gray, K. R., Aljabar, P., Heckemann, R. A., Hammers, A., & Rueckert, D. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.09.065 · Cited by 469
Association between Functional Connectivity Hubs and Brain Networks
Tomasi, D. G., & Volkow, N. D. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq268 · Cited by 441
Functional connectivity hubs in the human brain
Tomasi, D., & Volkow, N. D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.024 · Cited by 367
2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348
Self-citation
Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in Aging
Mormino, E. C., Smiljic, A., Hayenga, A. O., Onami, S. H., Greicius, M. D., Rabinovici, G. D., Janabi, M., Baker, S. L., Yen, I. V., Madison, C. M., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr025 · Cited by 344
Self-citation
Neuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304
The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
Jagust, W. J., Landau, S. M., Koeppe, R. A., Reiman, E. M., Chen, K., Mathis, C. A., Price, J. C., Foster, N. L., & Wang, A. Y. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.001 · Cited by 302
Self-citation
Gender differences in brain functional connectivity density
Tomasi, D. G., & Volkow, N. D. (2011) · Human Brain Mapping · doi:10.1002/hbm.21252 · Cited by 286
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
Walhovd, K. B., Fjell, A. M., Brewer, J., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jennings, R. G., Karow, D., Dale, A. M., & Initiative, T. A. D. N. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1809 · Cited by 279
Sex biology contributions to vulnerability to Alzheimer's disease: a think tank convened by the Women's Alzheimer's Research Initiative
Snyder, H. M., Asthana, S., Bain, L., Brinton, R., Craft, S., Dubal, D. B., Espeland, M. A., Gatz, M., Mielke, M. M., Raber, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.004 · Cited by 262
Multi-modal classification of Alzheimer's disease using nonlinear graph fusion
Tong, T., Gray, K. R., Gao, Q., Chen, L., & Rueckert, D. (2016) · Pattern Recognition · doi:10.1016/j.patcog.2016.10.009 · Cited by 271
Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
Brown, R. K. J., Bohnen, N. I., Wong, K. K., Minoshima, S., & Frey, K. A. (2014) · RadioGraphics · doi:10.1148/rg.343135065 · Cited by 256
Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse
Frère, S. G. A., & Slutsky, I. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.028 · Cited by 242
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.033 · Cited by 234
Self-citation
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 227
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Ashton, N. J., Hye, A., Rajkumar, A. P., Leuzy, A., Snowden, S. G., Suárez‐Calvet, M., Karikari, T. K., Schöll, M., Joie, R. L., Rabinovici, G. D., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0348-0 · Cited by 185
Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease
Gray, K. R., Wolz, R., Heckemann, R. A., Aljabar, P., Hammers, A., & Rueckert, D. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.071 · Cited by 185
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Initiative, A. D. N., Shen, L., Thompson, P. M., Potkin, S. G., Bertram, L., Farrer, L. A., Foroud, T., Green, R. C., Hu, X., Huentelman, M. J., et al. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9262-z · Cited by 176
Self-citation
Multisensory integration mechanisms during aging
Freiherr, J., Lundström, J. N., Habel, U., & Reetz, K. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00863 · Cited by 173
Report of the task force on designing clinical trials in early (predementia) AD
Aisen, P. S. S., Andrieu, S., Sampaio, C., Carrillo, M. C., Khachaturian, Z. S., Dubois, B., Feldman, H., Petersen, R. C., Siemers, E., Doody, R. S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318207b1b9 · Cited by 173
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
Chen, K., Langbaum, J. B. S., Fleisher, A., Ayutyanont, N., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.064 · Cited by 173
Self-citation
Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease
Protas, H. D., Chen, K., Langbaum, J. B. S., Fleisher, A. S., Alexander, G. E., Lee, W., Bandy, D., de Leon, M. J., Mosconi, L., Buckley, S., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.286 · Cited by 161
Self-citation
Alzheimer's Prevention Initiative: A Proposal to Evaluate Presymptomatic Treatments as Quickly as Possible
Reiman, E. M., Langbaum, J. B. S., & Tariot, P. N. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.91 · Cited by 160
Self-citation
Predicting conversion from MCI to AD by integrating rs-fMRI and structural MRI
Hojjati, S. H., Ebrahimzadeh, A., Khazaee, A., & Abbas Babajani-feremi, A. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.09.004 · Cited by 157
Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
Risacher, S. L., & Saykin, A. J. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185535 · Cited by 163
Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene
Valla, J., Yaari, R., Wolf, A. B., Kusne, Y., Beach, T. G., Roher, A. E., Corneveaux, J. J., Huentelman, M. J., Caselli, R. J., & Reiman, E. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100129 · Cited by 150
Self-citation
Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
Risacher, S. L., & Saykin, A. J. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1359312 · Cited by 155
Ushering in the study and treatment of preclinical Alzheimer disease
Langbaum, J. B. S., Fleisher, A., Chen, K., Ayutyanont, N., Lopera, F. J., Quiroz, Y. T., Caselli, R. J., Tariot, P. N., & Reiman, E. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.107 · Cited by 149
Self-citation
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
Risacher, S. L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00011 · Cited by 151
Optimizing power to track brain degeneration in Alzheimer’s disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects
Hua, X., Lee, S., Yanovsky, I., Leow, A. D., Chou, Y.-Y., Ho, A. J., Gutman, B., Toga, A. W., Jack, C. R., Bernstein, M. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.011 · Cited by 145
Self-citation
Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
Furst, A. J., Rabinovici, G. D., Rostomian, A. H., Steed, T., Alkalay, A., Racine, C. A., Miller, B. L., & Jagust, W. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.011 · Cited by 153
Self-citation
18F-FDG PET imaging analysis for computer aided Alzheimer’s diagnosis
Illán, I. A., Górriz, J. M., Ramı́rez, J., Salas-Gonzalez, D., López, M., Segovia, F., Chaves, R., Gómez-Río, M. M., & Puntonet, C. G. (2010) · Information Sciences · doi:10.1016/j.ins.2010.10.027 · Cited by 143
Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease
Roher, A. E., Garami, Z. F., Tyas, S. L., Maarouf, C. L., Kokjohn, T. A., Bëlohlávek, M., Vedders, L. J., Connor, D. J., Sabbagh, M. N., Beach, T. G., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.09.002 · Cited by 138
Neurovascular function in Alzheimer's disease patients and experimental models
Nicolakakis, N., & Hamel, E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.43 · Cited by 156
Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
Zhang, X., Alshakhshir, N., & Zhao, L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.662242 · Cited by 134
Brain imaging in the study of Alzheimer's disease
Reiman, E. M., & Jagust, W. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.075 · Cited by 139
Self-citation
Cerebral glucose metabolism in preclinical and prodromal Alzheimer’s disease
Herholz, K. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.136 · Cited by 138
Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample
Ekblad, L. L., Rinne, J. O., Puukka, P. J., Laine, H. K., Ahtiluoto, S., Sulkava, R. O., Viitanen, M. H., & Jula, A. (2017) · Diabetes Care · doi:10.2337/dc16-2001 · Cited by 129
Biomarkers in Alzheimer's disease drug development
Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 122
Current therapeutic targets for the treatment of Alzheimer’s disease
Grill, J. D., & Cummings, J. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 123
Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability
Elman, J. A., Madison, C. M., Baker, S. L., Vogel, J. W., Marks, S. M., Crowley, S., O’Neil, J. P., & Jagust, W. J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu259 · Cited by 122
Self-citation
Neural Correlates of Spatial Navigation Changes in Mild Cognitive Impairment and Alzheimer’s Disease
Vlček, K., & Laczó, J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00089 · Cited by 118
Insulin resistance in Alzheimer's disease
Diehl, T. C., Mullins, R. J., & Kapogiannis, D. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.005 · Cited by 124
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Soares, H. D., Chen, Y., Sabbagh, M. N., Rohrer, A., Schrijvers, E. M. C., & Breteler, M. M. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05066.x · Cited by 112
Brain glucose and acetoacetate metabolism: a comparison of young and older adults
Nugent, S., Tremblay, S., Chen, K. W., Ayutyanont, N., Roontiva, A., Castellano, C., Fortier, M., Roy, M., Courchesne‐Loyer, A., Bocti, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.027 · Cited by 113
Self-citation
Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease
Vlassenko, A. G., Gordon, B. A., Goyal, M. S., Su, Y., Blazey, T. M., Durbin, T. J., Couture, L. E., Christensen, J. J., Jafri, H., Morris, J. C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.014 · Cited by 107
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses
Toussaint, P., Perlbarg, V., Bellec, P., Désarnaud, S., Lacomblez, L., Doyon, J., Habert, M., & Benali, H. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.091 · Cited by 112
Glucose Metabolism during Resting State Reveals Abnormal Brain Networks Organization in the Alzheimer’s Disease and Mild Cognitive Impairment
Sanabria-Díaz, G., Martínez‐Montes, E., Melie‐García, L., & Initiative, T. A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068860 · Cited by 104
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104
Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E ε4 Allele
Langbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., Burns, C. M., Kaszniak, A. W., Reeder, S. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.30 · Cited by 100
Self-citation
Toward precision medicine in Alzheimer’s disease
Reitz, C. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.05 · Cited by 100
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort
on behalf of the MEMENTO cohort Study Group, Dufouil, C., Dubois, B., Vellas, B. J., Pasquier, F., Blanc, F., Hugon, J., Hanon, O., Dartigues, J., Harston, S., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0288-0 · Cited by 99
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
Pagani, M., Carli, F. D., Morbelli, S. D., Öberg, J., Chincarini, A., Frisoni, G. B., Galluzzi, S., Perneczky, R., Drzezga, A. E., van Berckel, B. N. M., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.11.007 · Cited by 99
Genetic variants in Alzheimer disease — molecular and brain network approaches
Gaiteri, C., Mostafavi, S., Honey, C. J., Jager, P. L. D., & Bennett, D. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.84 · Cited by 97
Brain aerobic glycolysis functions and Alzheimer’s disease
Vlassenko, A. G., & Raichle, M. E. (2014) · Clinical and Translational Imaging · doi:10.1007/s40336-014-0094-7 · Cited by 96
Metabolic Syndrome, Insulin Resistance, and Cognitive Dysfunction: Does Your Metabolic Profile Affect Your Brain?
Neergaard, J. S., Dragsbæk, K., Christiansen, C., Nielsen, H. B., Brix, S., Karsdal, M. A., & Henriksen, K. (2017) · Diabetes · doi:10.2337/db16-1444 · Cited by 103
Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment
Xu, L., Wu, X., Chen, K., & Yao, L. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.08.004 · Cited by 95
Self-citation
Alzheimer's Disease: The Downside of a Highly Evolved Parietal Lobe?
Bruner, E., & Jacobs, H. I. L. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122299 · Cited by 87
Can the emerging field of immunometabolism provide insights into neuroinflammation?
Lynch, M. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101719 · Cited by 88
Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes
Gibson, G. E., Hirsch, J. A., Cirio, R. T., Jordan, B. D., Fonzetti, P., & Elder, J. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.09.001 · Cited by 90
Clinical utility of FDG-PET for the clinical diagnosis in MCI
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Arbizu, J., Festari, C., Altomare, D., Walker, Z., Bouwman, F. H., Rivolta, J., Orini, S., Barthel, H., Agosta, F., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4039-7 · Cited by 90
Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals
Hua, X., Lee, S., Hibar, D. P., Yanovsky, I., Leow, A., Toga, A. W., Jack, C. R., Bernstein, M. A., Reiman, E. M., Harvey, D. J., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.104 · Cited by 84
Self-citation
Examining the Relationship between Head Trauma and Neurodegenerative Disease: A Review of Epidemiology, Pathology and Neuroimaging Techniques
Sundman, M. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000137 · Cited by 83
Pioglitazone Improves Reversal Learning and Exerts Mixed Cerebrovascular Effects in a Mouse Model of Alzheimer’s Disease with Combined Amyloid-β and Cerebrovascular Pathology
Papadopoulos, P., Rosa‐Neto, P., Rochford, J. M., & Hamel, É. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068612 · Cited by 75
Feature selection using factor analysis for Alzheimer's diagnosis using PET images
Salas-Gonzalez, D., Górriz, J. M., Ramı́rez, J., Illán, I. A., López, M., Segovia, F., Chaves, R., Padilla, P., Puntonet, C. G., & Initiative, T. A. D. N. (2010) · Medical Physics · doi:10.1118/1.3488894 · Cited by 74
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging
Reiman, E. M., Chen, K., Langbaum, J. B. S., Lee, W., Reschke, C., Bandy, D. J., Alexander, G. E., & Caselli, R. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.025 · Cited by 73
Self-citation
Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia
Wijtenburg, S. A., Kapogiannis, D., Korenic, S. A., Mullins, R. J., Tran, J., Gaston, F. E., Chen, S., Mustapić, M., Hong, L. E., & Rowland, L. M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.031 · Cited by 73
Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 74
Orthogonal latent space learning with feature weighting and graph learning for multimodal Alzheimer’s disease diagnosis
Chen, Z., Liu, Y., Zhang, Y., & Li, Q. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102698 · Cited by 69
Right Anterior Insula: Core Region of Hallucinations in Cognitive Neurodegenerative Diseases
Blanc, F., Noblet, V., Philippi, N., Cretin, B., Foucher, J., Armspach, J., Rousseau, F., & Initiative, T. A. D. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114774 · Cited by 69
18 F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18 F-Florbetapir in Alzheimer’s Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis
Khosravi, M., Peter, J., Wintering, N., Serruya, M. D., Shamchi, S. P., Werner, T. J., Alavi, A. A., & Newberg, A. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190220 · Cited by 70
Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative
Koppel, J., Sunday, S., Goldberg, T. E., Davies, P., Christen, E., & Greenwald, B. S. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.028 · Cited by 65
Radiogenomics for Precision Medicine With a Big Data Analytics Perspective
Panayides, A. S., Pattichis, M. S., Leandrou, S., Pitris, C., Constantinidou, A., & Pattichis, C. S. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2879381 · Cited by 66
Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
Salas, I. H., & Strooper, B. D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2690-9 · Cited by 68
Can functional magnetic resonance imaging improve success rates in central nervous system drug discovery?
Borsook, D., Hargreaves, R. J., & Becerra, L. R. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.584529 · Cited by 63
The road to precision medicine: Eliminating the “One Size Fits All” approach in Alzheimer’s disease
Behl, T., Kaur, I., Sehgal, A., Singh, S., Albarrati, A., Albratty, M., Najmi, A., Meraya, A. M., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113337 · Cited by 67
Physiological fluctuations in white matter are increased in Alzheimer's disease and correlate with neuroimaging and cognitive biomarkers
Makedonov, I., Chen, J. J., Masellis, M., & MacIntosh, B. J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.010 · Cited by 60
The nuclear receptor PPARγ as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer's disease
Nicolakakis, N. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00021 · Cited by 60
Integrating ADNI results into Alzheimer's disease drug development programs
Cummings, J. L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.016 · Cited by 59
Transgenic Mice Overexpressing APP and Transforming Growth Factor-β1 Feature Cognitive and Vascular Hallmarks of Alzheimer's Disease
Ongali, B., Nicolakakis, N., Lecrux, C., Aboulkassim, T., Rosa‐Neto, P., Papadopoulos, P., Tong, X., & Hamel, É. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100339 · Cited by 58
Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer’s dementia: a meta-analysis
Ma, H. R., Sheng, L. Q., Pan, P. L., Wang, G. D., Luo, R., Shi, H. C., Dai, Z. Y., & Zhong, J. G. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0114-z · Cited by 57
Clinical Trials in Predementia Stages of Alzheimer Disease
Pillai, J. A., & Cummings, J. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.01.002 · Cited by 58
Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease
Initiative, A. D. N., Habeck, C. G., Risacher, S. L., Lee, G. J., Glymour, M. M., Mormino, E. C., Mukherjee, S., Kim, S., Nho, K. T., DeCarli, C. S., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9208-x · Cited by 55
Apolipoprotein E regulates mitochondrial function through the PGC-1α-sirtuin 3 pathway
Yin, J., Nielsen, M., Carcione, T., Li, S., & Shi, J. (2019) · Aging · doi:10.18632/aging.102516 · Cited by 52
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets
Royea, J., & Hamel, É. (2020) · GeroScience · doi:10.1007/s11357-020-00231-y · Cited by 54
Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., Fonov, V., Jia, J., Gauthier, S. G., Rosa‐Neto, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047905 · Cited by 55

IC‐P1‐036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative
Lee, W., Langbaum, J. B. S., Chen, K., Recshke, C., Bandy, D. J., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.047
Self-citation
P2‐037: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative
Lee, W., Langbaum, J. B. S., Chen, K., Recshke, C., Bandy, D. J., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1118
Self-citation
P‐024: The pattern and severity of FDG pet abnormalities in Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative
Chen, K., Reiman, E. M., Alexander, G. E., Smilovici, O., Lee, W., Reschke, C., Bandy, D., Foster, N., Weiner, M. W., Koeppe, R. A., et al. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.04.240 · Cited by 1
Self-citation
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
Chen, K., Langbaum, J. B. S., Fleisher, A., Ayutyanont, N., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.064 · Cited by 173
Self-citation
O1–04–05: Six‐month cerebral metabolic declines in Alzheimer's disease, amnestic mild cognitive impairment and elderly normal control groups: Preliminary findings from the Alzheimer's disease neuroimaging initiative
Chen, K., Reiman, E. M., Alexander, G. E., Lee, W., Reschke, C., Smilovici, O., Bandy, D., Weiner, M. W., Koeppe, R. A., & Jagust, W. J. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.04.081
Self-citation

See all

Authors: Langbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., Jagust, W. J., & Reiman, E. M.
Affiliations: Banner Alzheimer’s Institute (US)
University of Arizona (US)
University of California San Diego (US)
University of Utah (US)
San Francisco VA Medical Center (US)
University of Michigan (US)
University of California, Berkeley (US)
Translational Genomics Research Institute (US)
Corresponding author: Reiman, Eric M.
ORCID: Langbaum, Jessica B.S.
Chen, Kewei
Lee, Wendy
Fleisher, Adam S.
Alexander, Gene E.
Foster, Norman L.
Weiner, Michael W.
Koeppe, Robert A.
Jagust, William J.
Reiman, Eric M.
Venue: NeuroImage
Publisher: Elsevier BV
Published: 2009-05
Volume: 45
Issue: 4
Pages: 1107-1116
ISSN: 1053-8119 (ISSN-L)
DOI: 10.1016/j.neuroimage.2008.12.072
PMC: PMC2886795
OpenAlex: W2016228161
Cited by: 279
References: 59
Citations by year: 2026: 5 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 26 · 2017: 14 · 2016: 21 · 2015: 15 · 2014: 22 · 2013: 26 · 2012: 24
FWCI: 18.55
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: NeuroImage (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5u01ag024904-10)
National Institute on Aging (U01-AG-024904, P30AG019610, U19AG010483)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords: Alzheimer's disease, amnestic mild cognitive impairment, FDG-PET, regional cerebral glucose metabolism, posterior cingulate cortex, precuneus, frontal and temporal cortex, disease severity, Mini-Mental State Examination, APOE ε4, ADNI
MeSH terms: Aged, Alzheimer Disease, Cerebral Cortex, Cognition Disorders, Female, Humans, Male, Middle Aged, Reference Values, Sensitivity and Specificity, Statistics as Topic, Reproducibility of Results, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks